https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/accrued-fees-and-other-revenue-receivable https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/accrued-vacation-current https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/amended-reports-10-k https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/amended-reports-10-k405 https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/business-acquisition-percentage-of-voting-interests-acquired https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/business-development https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/capital-required-for-capital-adequacy https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/cash https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/clinical-trials https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/commitments-and-contingencies https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/contract-liability https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/contract-with-customer-asset-net https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/convertible-debt-current https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/cost-of-revenue https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/current-federal-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/debt-convertible-effective-interest-rate https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/debt-face-amount https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/debt-interest-rate-effective-percentage-rate-range-maximum https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/debt-unamortized-discount https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-revenue-2 https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-tax-assets-charitable-contribution-carryforwards https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-foreign https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/defined-contribution-plan-maximum-annual-contribution-per-employee-amount https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/defined-contribution-plan-maximum-annual-contribution-per-employee-percent https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/derivative-liabilities https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/derivative-liabilities-current https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/dilutive-shares https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/embedded-derivative-gain-loss-on-embedded-derivative-net https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/eps https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/income-tax-expense-benefit https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/increase-decrease-in-customer-deposits https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/incremental-common-shares-attributable-to-conversion-of-debt-securities https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/insider-transactions-corporate-securities/purchases https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/insider-transactions-corporate-securities/sales https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/investment-owned-at-fair-value https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/investments-in-affiliates-subsidiaries-associates-and-joint-ventures https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/lease-cost https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/liabilities-assumed https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/liabilities-noncurrent https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/license-and-services-revenue https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/license-costs https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/long-term-notes-payable https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/net-income https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/noninterest-expense-offering-cost https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/notes-payable-current https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-lease-cost https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-lease-expense https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/other-income https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/other-noncash-expense https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/other-nonoperating-expense https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/patents-pending https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/patents-rejected https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/payments-for-fees https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/prepaid-insurance https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/proceeds-from-license-fees-received https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/professional-fees https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/public-float https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/revenue https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/royalty-expense https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-10-k405 https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-10ksb https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-10qsb https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-15-12g https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-ars https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-def-14c https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-defr14a https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-pre-14c https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-prer14a https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/sec-filings-sb-2 https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/secondary-offerings-form-424b2 https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/secondary-offerings-form-424b7 https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/secondary-offerings-form-del-am https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-issued-shares-issued-shares-issued-for-noncash-consideration https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-issued-shares-issued-value-issued-for-noncash-considerations https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/tax-rate-reconciliation-tax-credits-foreign https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/tax-rate-reconciliation-tax-credits-other https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/tax-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/tax-reconciliation-tax-credits-other https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/total-contract-liability https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/variable-lease-cost https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/regenerx-biopharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted